A phase III study evaluating the efficacy and safety of remimazolam (CNS 7056) compared with placebo and midazolam in patients undergoing colonoscopy
2018296 citationsJournal Articlegreen Open Access
Field-Weighted Citation Impact: 15.90
A phase III study evaluating the efficacy and safety of remimazolam (CNS 7056) compared with placebo and midazolam in patients undergoing colonoscopy | Researchclopedia